SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001683168-24-005092
Filing Date
2024-07-26
Accepted
2024-07-26 16:30:51
Documents
19

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT phio_s1.htm   iXBRL S-1 296980
2 GRAPHIC image_001.jpg GRAPHIC 3933
3 GRAPHIC image_002.jpg GRAPHIC 3424
4 OPINION OF HOGAN LOVELLS US LLP phio_ex0501.htm EX-5.1 7532
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM phio_ex2301.htm EX-23.1 2222
6 CALCULATION OF FILING FEE TABLES phio_ex107.htm EX-FILING FEES 39256
10 GRAPHIC image_003.jpg GRAPHIC 2551
  Complete submission text file 0001683168-24-005092.txt   586470

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE phio-20240726.xsd EX-101.SCH 3021
8 XBRL LABEL FILE phio-20240726_lab.xml EX-101.LAB 34767
9 XBRL PRESENTATION FILE phio-20240726_pre.xml EX-101.PRE 22721
21 EXTRACTED XBRL INSTANCE DOCUMENT phio_s1_htm.xml XML 3021
Mailing Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752
Business Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-281052 | Film No.: 241147381
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)